Ex Vivo High Salt Activated Tumor-Primed CD4+T Lymphocytes Exert a Potent Anti-Cancer Response

Area of Science:

• Immunology
• Cancer Research
• Cell Biology

Background:

• Cell-based immunotherapy is a promising cancer treatment strategy.
• Increased salt concentration in immune cell cultures can induce inflammatory differentiation.

Purpose of the Study:

• To investigate the effect of high salt concentration on the ex vivo expansion of tumor-primed CD4+ T cells.
• To determine if salt treatment enhances the effector phenotype and anti-tumor activity of CD4+ T cells.

Main Methods:

• CD4+ T cells were isolated from tumor-bearing and non-tumor-bearing mice.
• Cells were expanded ex vivo using high salt (NaCl) or mannitol controls, along with antibodies and cytokines.
• Tumor-specificity and anti-tumor efficacy were assessed in vitro and in vivo.

Main Results:

• High salt treatment resulted in a two-fold increase in Th1 and four-fold increase in Th17 expansion.
• Salt-expanded CD4+ T cells exhibited enhanced cytotoxicity against breast cancer cells and reduced tumor growth in vivo.
• Metabolic analysis indicated enhanced glycolysis and mitochondrial oxidation in high salt-treated cells.
• The transcription factor TonEBP/NFAT5 was identified as a key mediator of the salt-induced effector phenotype.

Conclusions:

• High salt-mediated ex vivo expansion effectively generates tumor-specific effector CD4+ T cells.
• This method enhances anti-tumor responses and holds potential for novel cancer immunotherapy applications.
• The findings highlight the role of TonEBP/NFAT5 in mediating salt-induced T cell differentiation and anti-tumor activity.